NUPERCAINAL ANESTHETIC OINTMENT 1% DIN 00623385
Health Canada record
| Active ingredient(s) | DIBUCAINE 1 % |
|---|---|
| Dosage form | Ointment |
| Route | Topical; Rectal |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | C05AD04 CINCHOCAINE |
| Original market date | 31-Dec-1944 |
| Current status date | 24-Nov-2016 |
| Source | Health Canada DPD |
Establishment licence of the holder
GlaxoSmithKline Inc. — licence 100630, currently licensed, last inspection rating C (2025-09-15).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DIBUCAINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00623407 | NUPERCAINAL ANTISEPTIC CREAM | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | Cream | DIBUCAINE 0.5 %; DOMIPHEN BROMIDE 0.05 % | Cancelled Post Market |